Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2025
Q4
Sell
-41,419
Closed -$609K 2880
2025
Q3
$609K Buy
41,419
+6,529
+19% +$66.5K ﹤0.01% 1628
2025
Q2
$343K Buy
34,890
+14,595
+72% +$121K ﹤0.01% 1881
2025
Q1
$148K Buy
20,295
+12,300
+154% +$108K ﹤0.01% 2246
2024
Q4
$62.5K Hold
7,995
﹤0.01% 2535
2024
Q3
$59.2K Hold
7,995
﹤0.01% 2538
2024
Q2
$64K Sell
7,995
-2
-0% -$18 ﹤0.01% 2500
2024
Q1
$93.1K Sell
7,997
-7,853
-50% -$86.9K ﹤0.01% 2415
2023
Q4
$177K Buy
15,850
+7,692
+94% +$70.7K ﹤0.01% 2150
2023
Q3
$126K Sell
8,158
-397
-5% -$6.66K ﹤0.01% 2247
2023
Q2
$162K Buy
8,555
+6,560
+329% +$115K ﹤0.01% 2060
2023
Q1
$30.4K Buy
+1,995
New +$26K ﹤0.01% 2700

Other funds holding ETNB

Zurich Cantonal Bank's ETNB Position: Q4 2025 in Review

Zurich Cantonal Bank sold out of 89bio (ETNB) in Q4 2025, closing a stake of 41,419 shares — an estimated $609K sold.

Zurich Cantonal Bank first reported a position in ETNB in Q1 2023 and held it in 11 quarters. The position peaked at $609K in Q3 2025. 2 funds tracked by Wall St. Rank hold ETNB as of Q4 2025.

  • Zurich Cantonal Bank reported no remaining 89bio position as of Q4 2025 after selling out during the quarter.
  • Zurich Cantonal Bank sold 41,419 89bio shares in Q4 2025, an estimated $609K.
  • Zurich Cantonal Bank first reported a position in 89bio in Q1 2023 and held it in 11 quarters.
  • Zurich Cantonal Bank's 89bio position peaked at $609K in Q3 2025.
  • 2 funds tracked by Wall St. Rank held 89bio as of Q4 2025.

Based on Zurich Cantonal Bank's 13F filing for Q4 2025, filed 27 Jan 2026.